IBO 8-K 2026-10-09

IMPACT BIOMEDICAL INC. (IBO) 8-K dated 2026-10-09 — accession 0001493152-26-046572. This URL is the filing, not the IBO hub.

IMPACT BIOMEDICAL INC. (IBO) is a biotechnology company listed on US.

IMPACT BIOMEDICAL INC. filed a 8-K on 2026-10-09. Accession 0001493152-26-046572.

Cached items: 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IBO revenue for 2025-12-31 was $32.0K. Net income was -$11.8M. Revenue was down 36.0% from 2022-12-31 to 2025-12-31. IBO currently screens at market cap $7.6M.

Not investment advice. The IBO SEC hub lists recent forms. The stock page is the research view.